ImmunoGen, Inc. carries a market capitalization of 1.14B, placing it among publicly traded companies globally.
| Market Cap | 1.14B |
| Enterprise Value | N/A |
ImmunoGen, Inc.'s stock has gained approximately 2.31775% over the past 52 weeks. The 50-day moving average sits at 4.38, while the 200-day moving average is 4.80.
| Beta (5Y) | N/A |
| 52-Week Price Change | 2.31775% |
| 50-Day Moving Average | 4.38 |
| 200-Day Moving Average | 4.80 |
| Average Volume (20 Days) | N/A |